Moreover, the prognostic value of RRM2 was comparable to the 70-gene signature and 21-gene recurrence score for breast cancer overall, and superior to these biomarkers and pathoclinical indicators for ER-negative breast cancers. Here, RRM2 is linked to breast cancer.